MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.medcli.2023.06.025

Медицинская библиотека · Medicina clinica · 2023

Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry.

Larrañaga-Moreira José M, Rodriguez-Serrano Ana I, Domínguez Fernando, Lalario Andrea, Zorio Esther, Barriales-Villa Roberto, Dilemma International Cardiomyopathy, Heart Failure Registry Investigators Group

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Descriptions on impact of SARS-CoV-2 infection in patients with cardiac amyloidosis (CA) are lacking. Our aim was to describe the prognosis of those patients.

METHODS

Retrospective observational study of unvaccinated patients with CA who developed SARS-CoV-2 infection enrolled in eleven centres (March 2020 to May 2021). Descriptive analysis of basal characteristics, hospitalization, mortality, and severe clinical course was performed. Comparisons to a population-based control group were made.

RESULTS

Forty-one patients were identified. Most patients had wild-type transthyretin CA (61%) and were on NYHA Class II-III (80.5%). CA patients were commonly hospitalized (73.2%) and those were more symptomatic than outpatients (p=0.035). The 24.4% of CA patients died as consequence of SARS-CoV-2 infection. Patients with CA had an increased risk of hospitalization [OR 6.23 (3.05-12.74), p<0.001] and mortality [OR 2.18 (1.01-4.68), p=0.047] when compared to control population after adjustment by age and sex. After a medium follow-time of 311 days, 41.5% of the CA cohort died.

CONCLUSIONS

SARS-CoV-2 infection is associated with high mortality and hospitalization rates in patients with CA, which exceed that expected by their sex and advanced age.

Для цитирования: Larrañaga-Moreira José M, Rodriguez-Serrano Ana I, Domínguez Fernando, Lalario Andrea, Zorio Esther, Barriales-Villa Roberto, Dilemma International Cardiomyopathy, Heart Failure Registry Investigators Group. Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry.. Medicina clinica. 2023. DOI: 10.1016/j.medcli.2023.06.025.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.